Putting the award page together from the records…
Putting the award page together from the records…
STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9).
Up for re-bid: ends 2027-01-31. Recompete brief → · CTN Data, Statistics, and Clinical Trial Support Center (DSC7) ↗
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
2 actions since 2023-09-14. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-05-29 | P00001 | Administrative change | $0 | STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 01/31/2027. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9). |
| 2023-09-14 | 0 | $1.25M | STANDARD AND HIGH DOSE ED BUPRENORPHINE INDUCTION. 09/15/2023 - 05/31/2026. N01DA-22-2253. TASK ORDER 75N95023F00005 (TO9). |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗